Isatuximab, DEXAMETHASONE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, DEXAMETHASONE, Isatuximab
EAE 115
Phase 2 small_molecule active
Quick answer
Isatuximab, DEXAMETHASONE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, POMALIDOMIDE, DEXAMETHASONE, Isatuximab for Multiple myeloma patients who received one prior line of therapy containing Lenalidomide and a Proteasome Inhibitor" is a Phase 2 program (small_molecule) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Multiple myeloma patients who received one prior line of therapy containing Lenalidomide and a Proteasome Inhibitor"
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active